National Healthcare Security Administration: The eleventh batch of drug procurement follows the principles of stability in clinical efficacy, ensuring quality, preventing bid rigging, and preventing internal circulation.

Today, the National Medical Insurance Administration issued the eleventh batch of national organized drug centralized procurement documents. In the formulation and modification process of this centralized procurement plan, the principle of "stability in clinical use, quality assurance, prevention of collusion, and prevention of internal consumption" was fully followed. In addition, this centralized procurement will further strengthen the implementation of the selection results. Selected enterprises are required to act as the first responsible party for supply guarantee, respond to medical institution orders in a timely manner, and complete distribution; medical institutions are required to prioritize the purchase of selected products, complete the agreed purchase volume on time according to the agreement, and fulfill the obligation of timely settlement of payments.